nodes	percent_of_prediction	percent_of_DWPC	metapath
Reboxetine—SLC6A4—Alzheimer's disease	0.258	0.587	CbGaD
Reboxetine—CYP2D6—Alzheimer's disease	0.182	0.413	CbGaD
Reboxetine—CYP2D6—Rivastigmine—Alzheimer's disease	0.0813	0.264	CbGbCtD
Reboxetine—CYP2D6—Donepezil—Alzheimer's disease	0.065	0.211	CbGbCtD
Reboxetine—CYP3A4—Rivastigmine—Alzheimer's disease	0.0517	0.168	CbGbCtD
Reboxetine—CYP2D6—Galantamine—Alzheimer's disease	0.0419	0.136	CbGbCtD
Reboxetine—CYP3A4—Donepezil—Alzheimer's disease	0.0413	0.134	CbGbCtD
Reboxetine—CYP3A4—Galantamine—Alzheimer's disease	0.0266	0.0865	CbGbCtD
Reboxetine—HTR2C—choroid plexus—Alzheimer's disease	0.0169	0.347	CbGeAlD
Reboxetine—SLC6A2—locus ceruleus—Alzheimer's disease	0.00874	0.179	CbGeAlD
Reboxetine—HTR2C—telencephalic ventricle—Alzheimer's disease	0.00496	0.102	CbGeAlD
Reboxetine—HTR2C—forebrain—Alzheimer's disease	0.0013	0.0265	CbGeAlD
Reboxetine—SLC6A4—forebrain—Alzheimer's disease	0.00123	0.0252	CbGeAlD
Reboxetine—HTR2C—telencephalon—Alzheimer's disease	0.00119	0.0244	CbGeAlD
Reboxetine—SLC6A4—telencephalon—Alzheimer's disease	0.00113	0.0231	CbGeAlD
Reboxetine—SLC6A2—forebrain—Alzheimer's disease	0.00108	0.0222	CbGeAlD
Reboxetine—SLC6A2—telencephalon—Alzheimer's disease	0.000995	0.0204	CbGeAlD
Reboxetine—ABCB1—blood vessel—Alzheimer's disease	0.000808	0.0165	CbGeAlD
Reboxetine—HTR2C—nervous system—Alzheimer's disease	0.000704	0.0144	CbGeAlD
Reboxetine—HTR2C—central nervous system—Alzheimer's disease	0.000678	0.0139	CbGeAlD
Reboxetine—SLC6A4—nervous system—Alzheimer's disease	0.000667	0.0137	CbGeAlD
Reboxetine—SLC6A4—central nervous system—Alzheimer's disease	0.000642	0.0132	CbGeAlD
Reboxetine—Atomoxetine—HTR6—Alzheimer's disease	0.000619	0.344	CrCbGaD
Reboxetine—CYP2D6—forebrain—Alzheimer's disease	0.000592	0.0121	CbGeAlD
Reboxetine—SLC6A2—nervous system—Alzheimer's disease	0.000587	0.012	CbGeAlD
Reboxetine—SLC6A2—central nervous system—Alzheimer's disease	0.000566	0.0116	CbGeAlD
Reboxetine—CYP2D6—telencephalon—Alzheimer's disease	0.000545	0.0112	CbGeAlD
Reboxetine—HTR2C—brain—Alzheimer's disease	0.000538	0.011	CbGeAlD
Reboxetine—SLC6A4—brain—Alzheimer's disease	0.00051	0.0104	CbGeAlD
Reboxetine—ABCB1—embryo—Alzheimer's disease	0.000482	0.00987	CbGeAlD
Reboxetine—SLC6A2—brain—Alzheimer's disease	0.000449	0.00919	CbGeAlD
Reboxetine—ABCB1—forebrain—Alzheimer's disease	0.000426	0.00873	CbGeAlD
Reboxetine—ABCB1—telencephalon—Alzheimer's disease	0.000392	0.00803	CbGeAlD
Reboxetine—Erectile dysfunction—Memantine—Alzheimer's disease	0.000364	0.00204	CcSEcCtD
Reboxetine—Ill-defined disorder—Galantamine—Alzheimer's disease	0.000363	0.00203	CcSEcCtD
Reboxetine—Anaemia—Galantamine—Alzheimer's disease	0.000361	0.00202	CcSEcCtD
Reboxetine—Dysuria—Rivastigmine—Alzheimer's disease	0.000361	0.00202	CcSEcCtD
Reboxetine—Agitation—Galantamine—Alzheimer's disease	0.000359	0.00201	CcSEcCtD
Reboxetine—Weight decreased—Memantine—Alzheimer's disease	0.000357	0.002	CcSEcCtD
Reboxetine—Pollakiuria—Rivastigmine—Alzheimer's disease	0.000357	0.002	CcSEcCtD
Reboxetine—Hyperglycaemia—Memantine—Alzheimer's disease	0.000356	0.002	CcSEcCtD
Reboxetine—Erectile dysfunction—Rivastigmine—Alzheimer's disease	0.000356	0.00199	CcSEcCtD
Reboxetine—Bradycardia—Donepezil—Alzheimer's disease	0.000354	0.00199	CcSEcCtD
Reboxetine—Malaise—Galantamine—Alzheimer's disease	0.000353	0.00198	CcSEcCtD
Reboxetine—Infestation—Memantine—Alzheimer's disease	0.000352	0.00197	CcSEcCtD
Reboxetine—Infestation NOS—Memantine—Alzheimer's disease	0.000352	0.00197	CcSEcCtD
Reboxetine—Vertigo—Galantamine—Alzheimer's disease	0.000351	0.00197	CcSEcCtD
Reboxetine—Syncope—Galantamine—Alzheimer's disease	0.000351	0.00196	CcSEcCtD
Reboxetine—Weight decreased—Rivastigmine—Alzheimer's disease	0.00035	0.00196	CcSEcCtD
Reboxetine—Rhinitis—Donepezil—Alzheimer's disease	0.000349	0.00196	CcSEcCtD
Reboxetine—Hyperglycaemia—Rivastigmine—Alzheimer's disease	0.000349	0.00195	CcSEcCtD
Reboxetine—Hallucination—Donepezil—Alzheimer's disease	0.000346	0.00194	CcSEcCtD
Reboxetine—Palpitations—Galantamine—Alzheimer's disease	0.000346	0.00194	CcSEcCtD
Reboxetine—Pharyngitis—Donepezil—Alzheimer's disease	0.000346	0.00194	CcSEcCtD
Reboxetine—Infestation—Rivastigmine—Alzheimer's disease	0.000345	0.00193	CcSEcCtD
Reboxetine—Infestation NOS—Rivastigmine—Alzheimer's disease	0.000345	0.00193	CcSEcCtD
Reboxetine—Urinary tract disorder—Donepezil—Alzheimer's disease	0.000344	0.00193	CcSEcCtD
Reboxetine—Loss of consciousness—Galantamine—Alzheimer's disease	0.000344	0.00193	CcSEcCtD
Reboxetine—Conjunctivitis—Memantine—Alzheimer's disease	0.000342	0.00192	CcSEcCtD
Reboxetine—Urinary tract infection—Memantine—Alzheimer's disease	0.000342	0.00192	CcSEcCtD
Reboxetine—Urethral disorder—Donepezil—Alzheimer's disease	0.000341	0.00191	CcSEcCtD
Reboxetine—Hypertension—Galantamine—Alzheimer's disease	0.000338	0.00189	CcSEcCtD
Reboxetine—Visual impairment—Donepezil—Alzheimer's disease	0.000336	0.00188	CcSEcCtD
Reboxetine—Urinary tract infection—Rivastigmine—Alzheimer's disease	0.000335	0.00188	CcSEcCtD
Reboxetine—Conjunctivitis—Rivastigmine—Alzheimer's disease	0.000335	0.00188	CcSEcCtD
Reboxetine—Chest pain—Galantamine—Alzheimer's disease	0.000333	0.00186	CcSEcCtD
Reboxetine—Epistaxis—Memantine—Alzheimer's disease	0.000332	0.00186	CcSEcCtD
Reboxetine—Anxiety—Galantamine—Alzheimer's disease	0.000332	0.00186	CcSEcCtD
Reboxetine—Unspecified disorder of skin and subcutaneous tissue—Galantamine—Alzheimer's disease	0.000331	0.00185	CcSEcCtD
Reboxetine—Sinusitis—Memantine—Alzheimer's disease	0.00033	0.00185	CcSEcCtD
Reboxetine—Sweating—Rivastigmine—Alzheimer's disease	0.00033	0.00185	CcSEcCtD
Reboxetine—Discomfort—Galantamine—Alzheimer's disease	0.000329	0.00184	CcSEcCtD
Reboxetine—CYP3A4—nervous system—Alzheimer's disease	0.000327	0.00669	CbGeAlD
Reboxetine—Dry mouth—Galantamine—Alzheimer's disease	0.000326	0.00182	CcSEcCtD
Reboxetine—Epistaxis—Rivastigmine—Alzheimer's disease	0.000325	0.00182	CcSEcCtD
Reboxetine—Tinnitus—Donepezil—Alzheimer's disease	0.000325	0.00182	CcSEcCtD
Reboxetine—Sinusitis—Rivastigmine—Alzheimer's disease	0.000323	0.00181	CcSEcCtD
Reboxetine—Confusional state—Galantamine—Alzheimer's disease	0.000322	0.0018	CcSEcCtD
Reboxetine—Bradycardia—Memantine—Alzheimer's disease	0.000322	0.0018	CcSEcCtD
Reboxetine—CYP2D6—nervous system—Alzheimer's disease	0.000322	0.00659	CbGeAlD
Reboxetine—Rhinitis—Memantine—Alzheimer's disease	0.000317	0.00178	CcSEcCtD
Reboxetine—Bradycardia—Rivastigmine—Alzheimer's disease	0.000315	0.00176	CcSEcCtD
Reboxetine—CYP3A4—central nervous system—Alzheimer's disease	0.000315	0.00644	CbGeAlD
Reboxetine—Hallucination—Memantine—Alzheimer's disease	0.000315	0.00176	CcSEcCtD
Reboxetine—Shock—Galantamine—Alzheimer's disease	0.000314	0.00176	CcSEcCtD
Reboxetine—Pharyngitis—Memantine—Alzheimer's disease	0.000314	0.00176	CcSEcCtD
Reboxetine—Nervous system disorder—Galantamine—Alzheimer's disease	0.000313	0.00175	CcSEcCtD
Reboxetine—Chills—Donepezil—Alzheimer's disease	0.000312	0.00175	CcSEcCtD
Reboxetine—Urinary tract disorder—Memantine—Alzheimer's disease	0.000312	0.00175	CcSEcCtD
Reboxetine—Tachycardia—Galantamine—Alzheimer's disease	0.000312	0.00174	CcSEcCtD
Reboxetine—Connective tissue disorder—Memantine—Alzheimer's disease	0.000311	0.00174	CcSEcCtD
Reboxetine—Rhinitis—Rivastigmine—Alzheimer's disease	0.00031	0.00174	CcSEcCtD
Reboxetine—Skin disorder—Galantamine—Alzheimer's disease	0.00031	0.00174	CcSEcCtD
Reboxetine—Urethral disorder—Memantine—Alzheimer's disease	0.00031	0.00174	CcSEcCtD
Reboxetine—CYP2D6—central nervous system—Alzheimer's disease	0.00031	0.00634	CbGeAlD
Reboxetine—Hyperhidrosis—Galantamine—Alzheimer's disease	0.000309	0.00173	CcSEcCtD
Reboxetine—Hallucination—Rivastigmine—Alzheimer's disease	0.000308	0.00172	CcSEcCtD
Reboxetine—Pharyngitis—Rivastigmine—Alzheimer's disease	0.000307	0.00172	CcSEcCtD
Reboxetine—Urinary tract disorder—Rivastigmine—Alzheimer's disease	0.000305	0.00171	CcSEcCtD
Reboxetine—Mental disorder—Donepezil—Alzheimer's disease	0.000305	0.00171	CcSEcCtD
Reboxetine—Visual impairment—Memantine—Alzheimer's disease	0.000305	0.00171	CcSEcCtD
Reboxetine—Anorexia—Galantamine—Alzheimer's disease	0.000304	0.0017	CcSEcCtD
Reboxetine—Connective tissue disorder—Rivastigmine—Alzheimer's disease	0.000304	0.0017	CcSEcCtD
Reboxetine—Urethral disorder—Rivastigmine—Alzheimer's disease	0.000303	0.0017	CcSEcCtD
Reboxetine—Malnutrition—Donepezil—Alzheimer's disease	0.000303	0.0017	CcSEcCtD
Reboxetine—CYP2D6—cerebellum—Alzheimer's disease	0.000303	0.0062	CbGeAlD
Reboxetine—Hypotension—Galantamine—Alzheimer's disease	0.000298	0.00167	CcSEcCtD
Reboxetine—Visual impairment—Rivastigmine—Alzheimer's disease	0.000298	0.00167	CcSEcCtD
Reboxetine—Tension—Donepezil—Alzheimer's disease	0.000297	0.00167	CcSEcCtD
Reboxetine—Dysgeusia—Donepezil—Alzheimer's disease	0.000297	0.00166	CcSEcCtD
Reboxetine—Eye disorder—Memantine—Alzheimer's disease	0.000295	0.00165	CcSEcCtD
Reboxetine—Tinnitus—Memantine—Alzheimer's disease	0.000295	0.00165	CcSEcCtD
Reboxetine—Nervousness—Donepezil—Alzheimer's disease	0.000294	0.00165	CcSEcCtD
Reboxetine—Cardiac disorder—Memantine—Alzheimer's disease	0.000293	0.00164	CcSEcCtD
Reboxetine—Eye disorder—Rivastigmine—Alzheimer's disease	0.000289	0.00162	CcSEcCtD
Reboxetine—Insomnia—Galantamine—Alzheimer's disease	0.000289	0.00162	CcSEcCtD
Reboxetine—Tinnitus—Rivastigmine—Alzheimer's disease	0.000288	0.00162	CcSEcCtD
Reboxetine—Cardiac disorder—Rivastigmine—Alzheimer's disease	0.000287	0.00161	CcSEcCtD
Reboxetine—Angiopathy—Memantine—Alzheimer's disease	0.000287	0.00161	CcSEcCtD
Reboxetine—Paraesthesia—Galantamine—Alzheimer's disease	0.000287	0.00161	CcSEcCtD
Reboxetine—Immune system disorder—Memantine—Alzheimer's disease	0.000286	0.0016	CcSEcCtD
Reboxetine—Mediastinal disorder—Memantine—Alzheimer's disease	0.000285	0.0016	CcSEcCtD
Reboxetine—Tremor—Donepezil—Alzheimer's disease	0.000284	0.00159	CcSEcCtD
Reboxetine—Somnolence—Galantamine—Alzheimer's disease	0.000284	0.00159	CcSEcCtD
Reboxetine—Chills—Memantine—Alzheimer's disease	0.000284	0.00159	CcSEcCtD
Reboxetine—Ill-defined disorder—Donepezil—Alzheimer's disease	0.000281	0.00158	CcSEcCtD
Reboxetine—Dyspepsia—Galantamine—Alzheimer's disease	0.000281	0.00157	CcSEcCtD
Reboxetine—Angiopathy—Rivastigmine—Alzheimer's disease	0.000281	0.00157	CcSEcCtD
Reboxetine—Anaemia—Donepezil—Alzheimer's disease	0.00028	0.00157	CcSEcCtD
Reboxetine—Mediastinal disorder—Rivastigmine—Alzheimer's disease	0.000279	0.00156	CcSEcCtD
Reboxetine—Agitation—Donepezil—Alzheimer's disease	0.000279	0.00156	CcSEcCtD
Reboxetine—Chills—Rivastigmine—Alzheimer's disease	0.000278	0.00155	CcSEcCtD
Reboxetine—Decreased appetite—Galantamine—Alzheimer's disease	0.000277	0.00155	CcSEcCtD
Reboxetine—Mental disorder—Memantine—Alzheimer's disease	0.000277	0.00155	CcSEcCtD
Reboxetine—Gastrointestinal disorder—Galantamine—Alzheimer's disease	0.000276	0.00154	CcSEcCtD
Reboxetine—Malnutrition—Memantine—Alzheimer's disease	0.000275	0.00154	CcSEcCtD
Reboxetine—Malaise—Donepezil—Alzheimer's disease	0.000273	0.00153	CcSEcCtD
Reboxetine—Constipation—Galantamine—Alzheimer's disease	0.000273	0.00153	CcSEcCtD
Reboxetine—Vertigo—Donepezil—Alzheimer's disease	0.000272	0.00153	CcSEcCtD
Reboxetine—Syncope—Donepezil—Alzheimer's disease	0.000272	0.00152	CcSEcCtD
Reboxetine—Mental disorder—Rivastigmine—Alzheimer's disease	0.000271	0.00152	CcSEcCtD
Reboxetine—Tension—Memantine—Alzheimer's disease	0.00027	0.00151	CcSEcCtD
Reboxetine—Dysgeusia—Memantine—Alzheimer's disease	0.000269	0.00151	CcSEcCtD
Reboxetine—Malnutrition—Rivastigmine—Alzheimer's disease	0.000269	0.00151	CcSEcCtD
Reboxetine—Nervousness—Memantine—Alzheimer's disease	0.000267	0.0015	CcSEcCtD
Reboxetine—Loss of consciousness—Donepezil—Alzheimer's disease	0.000266	0.00149	CcSEcCtD
Reboxetine—Tension—Rivastigmine—Alzheimer's disease	0.000264	0.00148	CcSEcCtD
Reboxetine—Dysgeusia—Rivastigmine—Alzheimer's disease	0.000264	0.00148	CcSEcCtD
Reboxetine—Feeling abnormal—Galantamine—Alzheimer's disease	0.000263	0.00147	CcSEcCtD
Reboxetine—Hypertension—Donepezil—Alzheimer's disease	0.000262	0.00147	CcSEcCtD
Reboxetine—Benzatropine—CYP2D6—Alzheimer's disease	0.000262	0.145	CrCbGaD
Reboxetine—Nervousness—Rivastigmine—Alzheimer's disease	0.000261	0.00146	CcSEcCtD
Reboxetine—Gastrointestinal pain—Galantamine—Alzheimer's disease	0.000261	0.00146	CcSEcCtD
Reboxetine—Chest pain—Donepezil—Alzheimer's disease	0.000258	0.00145	CcSEcCtD
Reboxetine—Tremor—Memantine—Alzheimer's disease	0.000258	0.00144	CcSEcCtD
Reboxetine—Anxiety—Donepezil—Alzheimer's disease	0.000257	0.00144	CcSEcCtD
Reboxetine—Ill-defined disorder—Memantine—Alzheimer's disease	0.000255	0.00143	CcSEcCtD
Reboxetine—Discomfort—Donepezil—Alzheimer's disease	0.000255	0.00143	CcSEcCtD
Reboxetine—Anaemia—Memantine—Alzheimer's disease	0.000254	0.00142	CcSEcCtD
Reboxetine—Agitation—Memantine—Alzheimer's disease	0.000253	0.00142	CcSEcCtD
Reboxetine—Dry mouth—Donepezil—Alzheimer's disease	0.000252	0.00141	CcSEcCtD
Reboxetine—Abdominal pain—Galantamine—Alzheimer's disease	0.000252	0.00141	CcSEcCtD
Reboxetine—Body temperature increased—Galantamine—Alzheimer's disease	0.000252	0.00141	CcSEcCtD
Reboxetine—Tremor—Rivastigmine—Alzheimer's disease	0.000252	0.00141	CcSEcCtD
Reboxetine—Ill-defined disorder—Rivastigmine—Alzheimer's disease	0.00025	0.0014	CcSEcCtD
Reboxetine—Confusional state—Donepezil—Alzheimer's disease	0.000249	0.0014	CcSEcCtD
Reboxetine—Anaemia—Rivastigmine—Alzheimer's disease	0.000249	0.00139	CcSEcCtD
Reboxetine—Malaise—Memantine—Alzheimer's disease	0.000248	0.00139	CcSEcCtD
Reboxetine—Agitation—Rivastigmine—Alzheimer's disease	0.000247	0.00139	CcSEcCtD
Reboxetine—Vertigo—Memantine—Alzheimer's disease	0.000247	0.00138	CcSEcCtD
Reboxetine—Syncope—Memantine—Alzheimer's disease	0.000247	0.00138	CcSEcCtD
Reboxetine—Leukopenia—Memantine—Alzheimer's disease	0.000246	0.00138	CcSEcCtD
Reboxetine—CYP2D6—brain—Alzheimer's disease	0.000246	0.00503	CbGeAlD
Reboxetine—Infection—Donepezil—Alzheimer's disease	0.000246	0.00138	CcSEcCtD
Reboxetine—Shock—Donepezil—Alzheimer's disease	0.000243	0.00136	CcSEcCtD
Reboxetine—Palpitations—Memantine—Alzheimer's disease	0.000243	0.00136	CcSEcCtD
Reboxetine—Malaise—Rivastigmine—Alzheimer's disease	0.000243	0.00136	CcSEcCtD
Reboxetine—Nervous system disorder—Donepezil—Alzheimer's disease	0.000243	0.00136	CcSEcCtD
Reboxetine—Vertigo—Rivastigmine—Alzheimer's disease	0.000242	0.00135	CcSEcCtD
Reboxetine—Loss of consciousness—Memantine—Alzheimer's disease	0.000242	0.00135	CcSEcCtD
Reboxetine—Syncope—Rivastigmine—Alzheimer's disease	0.000241	0.00135	CcSEcCtD
Reboxetine—Hyperhidrosis—Donepezil—Alzheimer's disease	0.000239	0.00134	CcSEcCtD
Reboxetine—Palpitations—Rivastigmine—Alzheimer's disease	0.000238	0.00133	CcSEcCtD
Reboxetine—Hypertension—Memantine—Alzheimer's disease	0.000238	0.00133	CcSEcCtD
Reboxetine—Atomoxetine—SLC6A4—Alzheimer's disease	0.000237	0.132	CrCbGaD
Reboxetine—Loss of consciousness—Rivastigmine—Alzheimer's disease	0.000237	0.00133	CcSEcCtD
Reboxetine—Anorexia—Donepezil—Alzheimer's disease	0.000236	0.00132	CcSEcCtD
Reboxetine—Hypersensitivity—Galantamine—Alzheimer's disease	0.000235	0.00132	CcSEcCtD
Reboxetine—Chest pain—Memantine—Alzheimer's disease	0.000234	0.00131	CcSEcCtD
Reboxetine—Anxiety—Memantine—Alzheimer's disease	0.000233	0.00131	CcSEcCtD
Reboxetine—Hypertension—Rivastigmine—Alzheimer's disease	0.000232	0.0013	CcSEcCtD
Reboxetine—Discomfort—Memantine—Alzheimer's disease	0.000231	0.0013	CcSEcCtD
Reboxetine—ABCB1—nervous system—Alzheimer's disease	0.000231	0.00474	CbGeAlD
Reboxetine—Hypotension—Donepezil—Alzheimer's disease	0.000231	0.00129	CcSEcCtD
Reboxetine—Chest pain—Rivastigmine—Alzheimer's disease	0.000229	0.00128	CcSEcCtD
Reboxetine—Dry mouth—Memantine—Alzheimer's disease	0.000229	0.00128	CcSEcCtD
Reboxetine—Asthenia—Galantamine—Alzheimer's disease	0.000229	0.00128	CcSEcCtD
Reboxetine—Anxiety—Rivastigmine—Alzheimer's disease	0.000228	0.00128	CcSEcCtD
Reboxetine—Unspecified disorder of skin and subcutaneous tissue—Rivastigmine—Alzheimer's disease	0.000228	0.00127	CcSEcCtD
Reboxetine—Confusional state—Memantine—Alzheimer's disease	0.000226	0.00127	CcSEcCtD
Reboxetine—Discomfort—Rivastigmine—Alzheimer's disease	0.000226	0.00127	CcSEcCtD
Reboxetine—Dry mouth—Rivastigmine—Alzheimer's disease	0.000224	0.00126	CcSEcCtD
Reboxetine—Insomnia—Donepezil—Alzheimer's disease	0.000224	0.00125	CcSEcCtD
Reboxetine—Infection—Memantine—Alzheimer's disease	0.000223	0.00125	CcSEcCtD
Reboxetine—ABCB1—central nervous system—Alzheimer's disease	0.000223	0.00456	CbGeAlD
Reboxetine—Paraesthesia—Donepezil—Alzheimer's disease	0.000222	0.00124	CcSEcCtD
Reboxetine—Confusional state—Rivastigmine—Alzheimer's disease	0.000222	0.00124	CcSEcCtD
Reboxetine—Shock—Memantine—Alzheimer's disease	0.000221	0.00124	CcSEcCtD
Reboxetine—Dyspnoea—Donepezil—Alzheimer's disease	0.000221	0.00124	CcSEcCtD
Reboxetine—Nervous system disorder—Memantine—Alzheimer's disease	0.00022	0.00123	CcSEcCtD
Reboxetine—Somnolence—Donepezil—Alzheimer's disease	0.00022	0.00123	CcSEcCtD
Reboxetine—Tachycardia—Memantine—Alzheimer's disease	0.000219	0.00123	CcSEcCtD
Reboxetine—Diarrhoea—Galantamine—Alzheimer's disease	0.000218	0.00122	CcSEcCtD
Reboxetine—Infection—Rivastigmine—Alzheimer's disease	0.000218	0.00122	CcSEcCtD
Reboxetine—Skin disorder—Memantine—Alzheimer's disease	0.000218	0.00122	CcSEcCtD
Reboxetine—Dyspepsia—Donepezil—Alzheimer's disease	0.000218	0.00122	CcSEcCtD
Reboxetine—ABCB1—cerebellum—Alzheimer's disease	0.000218	0.00446	CbGeAlD
Reboxetine—Hyperhidrosis—Memantine—Alzheimer's disease	0.000217	0.00122	CcSEcCtD
Reboxetine—Shock—Rivastigmine—Alzheimer's disease	0.000216	0.00121	CcSEcCtD
Reboxetine—Nervous system disorder—Rivastigmine—Alzheimer's disease	0.000215	0.00121	CcSEcCtD
Reboxetine—Decreased appetite—Donepezil—Alzheimer's disease	0.000215	0.0012	CcSEcCtD
Reboxetine—Tachycardia—Rivastigmine—Alzheimer's disease	0.000214	0.0012	CcSEcCtD
Reboxetine—Anorexia—Memantine—Alzheimer's disease	0.000214	0.0012	CcSEcCtD
Reboxetine—Gastrointestinal disorder—Donepezil—Alzheimer's disease	0.000214	0.0012	CcSEcCtD
Reboxetine—Skin disorder—Rivastigmine—Alzheimer's disease	0.000213	0.0012	CcSEcCtD
Reboxetine—Hyperhidrosis—Rivastigmine—Alzheimer's disease	0.000212	0.00119	CcSEcCtD
Reboxetine—Constipation—Donepezil—Alzheimer's disease	0.000212	0.00118	CcSEcCtD
Reboxetine—Dizziness—Galantamine—Alzheimer's disease	0.000211	0.00118	CcSEcCtD
Reboxetine—Hypotension—Memantine—Alzheimer's disease	0.00021	0.00118	CcSEcCtD
Reboxetine—Anorexia—Rivastigmine—Alzheimer's disease	0.000209	0.00117	CcSEcCtD
Reboxetine—Hypotension—Rivastigmine—Alzheimer's disease	0.000205	0.00115	CcSEcCtD
Reboxetine—Feeling abnormal—Donepezil—Alzheimer's disease	0.000204	0.00114	CcSEcCtD
Reboxetine—Insomnia—Memantine—Alzheimer's disease	0.000203	0.00114	CcSEcCtD
Reboxetine—Vomiting—Galantamine—Alzheimer's disease	0.000203	0.00114	CcSEcCtD
Reboxetine—Gastrointestinal pain—Donepezil—Alzheimer's disease	0.000202	0.00113	CcSEcCtD
Reboxetine—Paraesthesia—Memantine—Alzheimer's disease	0.000202	0.00113	CcSEcCtD
Reboxetine—Rash—Galantamine—Alzheimer's disease	0.000201	0.00113	CcSEcCtD
Reboxetine—Dermatitis—Galantamine—Alzheimer's disease	0.000201	0.00113	CcSEcCtD
Reboxetine—Dyspnoea—Memantine—Alzheimer's disease	0.0002	0.00112	CcSEcCtD
Reboxetine—Headache—Galantamine—Alzheimer's disease	0.0002	0.00112	CcSEcCtD
Reboxetine—Somnolence—Memantine—Alzheimer's disease	0.0002	0.00112	CcSEcCtD
Reboxetine—Insomnia—Rivastigmine—Alzheimer's disease	0.000199	0.00111	CcSEcCtD
Reboxetine—Dyspepsia—Memantine—Alzheimer's disease	0.000198	0.00111	CcSEcCtD
Reboxetine—Diphenhydramine—PTGS1—Alzheimer's disease	0.000198	0.11	CrCbGaD
Reboxetine—Paraesthesia—Rivastigmine—Alzheimer's disease	0.000197	0.00111	CcSEcCtD
Reboxetine—Urticaria—Donepezil—Alzheimer's disease	0.000197	0.0011	CcSEcCtD
Reboxetine—Dyspnoea—Rivastigmine—Alzheimer's disease	0.000196	0.0011	CcSEcCtD
Reboxetine—Abdominal pain—Donepezil—Alzheimer's disease	0.000196	0.0011	CcSEcCtD
Reboxetine—Body temperature increased—Donepezil—Alzheimer's disease	0.000196	0.0011	CcSEcCtD
Reboxetine—Somnolence—Rivastigmine—Alzheimer's disease	0.000195	0.00109	CcSEcCtD
Reboxetine—Decreased appetite—Memantine—Alzheimer's disease	0.000195	0.00109	CcSEcCtD
Reboxetine—Gastrointestinal disorder—Memantine—Alzheimer's disease	0.000194	0.00109	CcSEcCtD
Reboxetine—Dyspepsia—Rivastigmine—Alzheimer's disease	0.000193	0.00108	CcSEcCtD
Reboxetine—Constipation—Memantine—Alzheimer's disease	0.000192	0.00108	CcSEcCtD
Reboxetine—Decreased appetite—Rivastigmine—Alzheimer's disease	0.000191	0.00107	CcSEcCtD
Reboxetine—Gastrointestinal disorder—Rivastigmine—Alzheimer's disease	0.00019	0.00106	CcSEcCtD
Reboxetine—Nausea—Galantamine—Alzheimer's disease	0.00019	0.00106	CcSEcCtD
Reboxetine—Constipation—Rivastigmine—Alzheimer's disease	0.000188	0.00105	CcSEcCtD
Reboxetine—Feeling abnormal—Memantine—Alzheimer's disease	0.000185	0.00104	CcSEcCtD
Reboxetine—Gastrointestinal pain—Memantine—Alzheimer's disease	0.000184	0.00103	CcSEcCtD
Reboxetine—Hypersensitivity—Donepezil—Alzheimer's disease	0.000182	0.00102	CcSEcCtD
Reboxetine—Atomoxetine—HTR2A—Alzheimer's disease	0.000182	0.101	CrCbGaD
Reboxetine—Feeling abnormal—Rivastigmine—Alzheimer's disease	0.000181	0.00101	CcSEcCtD
Reboxetine—Gastrointestinal pain—Rivastigmine—Alzheimer's disease	0.00018	0.00101	CcSEcCtD
Reboxetine—Urticaria—Memantine—Alzheimer's disease	0.000178	0.000999	CcSEcCtD
Reboxetine—Body temperature increased—Memantine—Alzheimer's disease	0.000178	0.000994	CcSEcCtD
Reboxetine—Abdominal pain—Memantine—Alzheimer's disease	0.000178	0.000994	CcSEcCtD
Reboxetine—Asthenia—Donepezil—Alzheimer's disease	0.000177	0.000994	CcSEcCtD
Reboxetine—ABCB1—brain—Alzheimer's disease	0.000177	0.00362	CbGeAlD
Reboxetine—Urticaria—Rivastigmine—Alzheimer's disease	0.000175	0.000978	CcSEcCtD
Reboxetine—Body temperature increased—Rivastigmine—Alzheimer's disease	0.000174	0.000973	CcSEcCtD
Reboxetine—Abdominal pain—Rivastigmine—Alzheimer's disease	0.000174	0.000973	CcSEcCtD
Reboxetine—Diarrhoea—Donepezil—Alzheimer's disease	0.000169	0.000948	CcSEcCtD
Reboxetine—Atomoxetine—CYP2D6—Alzheimer's disease	0.000167	0.0926	CrCbGaD
Reboxetine—Hypersensitivity—Memantine—Alzheimer's disease	0.000165	0.000927	CcSEcCtD
Reboxetine—Dizziness—Donepezil—Alzheimer's disease	0.000164	0.000916	CcSEcCtD
Reboxetine—Hypersensitivity—Rivastigmine—Alzheimer's disease	0.000162	0.000907	CcSEcCtD
Reboxetine—Asthenia—Memantine—Alzheimer's disease	0.000161	0.000903	CcSEcCtD
Reboxetine—Asthenia—Rivastigmine—Alzheimer's disease	0.000158	0.000883	CcSEcCtD
Reboxetine—Vomiting—Donepezil—Alzheimer's disease	0.000157	0.000881	CcSEcCtD
Reboxetine—Rash—Donepezil—Alzheimer's disease	0.000156	0.000874	CcSEcCtD
Reboxetine—Dermatitis—Donepezil—Alzheimer's disease	0.000156	0.000873	CcSEcCtD
Reboxetine—Headache—Donepezil—Alzheimer's disease	0.000155	0.000868	CcSEcCtD
Reboxetine—Diarrhoea—Memantine—Alzheimer's disease	0.000154	0.000861	CcSEcCtD
Reboxetine—Diarrhoea—Rivastigmine—Alzheimer's disease	0.00015	0.000842	CcSEcCtD
Reboxetine—Dizziness—Memantine—Alzheimer's disease	0.000149	0.000832	CcSEcCtD
Reboxetine—Nausea—Donepezil—Alzheimer's disease	0.000147	0.000823	CcSEcCtD
Reboxetine—Dizziness—Rivastigmine—Alzheimer's disease	0.000145	0.000814	CcSEcCtD
Reboxetine—Vomiting—Memantine—Alzheimer's disease	0.000143	0.0008	CcSEcCtD
Reboxetine—Rash—Memantine—Alzheimer's disease	0.000142	0.000793	CcSEcCtD
Reboxetine—Dermatitis—Memantine—Alzheimer's disease	0.000141	0.000792	CcSEcCtD
Reboxetine—Headache—Memantine—Alzheimer's disease	0.000141	0.000788	CcSEcCtD
Reboxetine—Vomiting—Rivastigmine—Alzheimer's disease	0.00014	0.000783	CcSEcCtD
Reboxetine—Rash—Rivastigmine—Alzheimer's disease	0.000139	0.000776	CcSEcCtD
Reboxetine—Dermatitis—Rivastigmine—Alzheimer's disease	0.000138	0.000775	CcSEcCtD
Reboxetine—Headache—Rivastigmine—Alzheimer's disease	0.000138	0.000771	CcSEcCtD
Reboxetine—Diphenhydramine—CYP2D6—Alzheimer's disease	0.000135	0.0748	CrCbGaD
Reboxetine—Nausea—Memantine—Alzheimer's disease	0.000133	0.000747	CcSEcCtD
Reboxetine—Nausea—Rivastigmine—Alzheimer's disease	0.000131	0.000731	CcSEcCtD
Reboxetine—HTR2C—GPCR ligand binding—CRH—Alzheimer's disease	3.51e-05	0.00153	CbGpPWpGaD
Reboxetine—HTR2C—G alpha (q) signalling events—F2—Alzheimer's disease	3.48e-05	0.00151	CbGpPWpGaD
Reboxetine—HTR2C—Signaling by GPCR—PYY—Alzheimer's disease	3.42e-05	0.00149	CbGpPWpGaD
Reboxetine—ABCB1—Integrated Pancreatic Cancer Pathway—GSK3A—Alzheimer's disease	3.35e-05	0.00146	CbGpPWpGaD
Reboxetine—SLC6A2—Transmembrane transport of small molecules—TF—Alzheimer's disease	3.33e-05	0.00145	CbGpPWpGaD
Reboxetine—HTR2C—GPCR ligand binding—NPS—Alzheimer's disease	3.32e-05	0.00145	CbGpPWpGaD
Reboxetine—SLC6A4—SIDS Susceptibility Pathways—VEGFA—Alzheimer's disease	3.32e-05	0.00145	CbGpPWpGaD
Reboxetine—ABCB1—Integrated Pancreatic Cancer Pathway—APP—Alzheimer's disease	3.29e-05	0.00143	CbGpPWpGaD
Reboxetine—ABCB1—Transmembrane transport of small molecules—SLC30A6—Alzheimer's disease	3.23e-05	0.00141	CbGpPWpGaD
Reboxetine—SLC6A4—NRF2 pathway—TGFB1—Alzheimer's disease	3.21e-05	0.0014	CbGpPWpGaD
Reboxetine—HTR2C—GPCR ligand binding—SST—Alzheimer's disease	3.17e-05	0.00138	CbGpPWpGaD
Reboxetine—HTR2C—GPCR downstream signaling—HTR6—Alzheimer's disease	3.15e-05	0.00137	CbGpPWpGaD
Reboxetine—HTR2C—GPCRs, Class A Rhodopsin-like—CCR5—Alzheimer's disease	3.13e-05	0.00136	CbGpPWpGaD
Reboxetine—CYP3A4—Biological oxidations—MAOB—Alzheimer's disease	3.13e-05	0.00136	CbGpPWpGaD
Reboxetine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—F2—Alzheimer's disease	3.11e-05	0.00135	CbGpPWpGaD
Reboxetine—HTR2C—GPCR ligand binding—APP—Alzheimer's disease	3.09e-05	0.00135	CbGpPWpGaD
Reboxetine—HTR2C—GPCRs, Class A Rhodopsin-like—HTR2A—Alzheimer's disease	3.06e-05	0.00133	CbGpPWpGaD
Reboxetine—HTR2C—Signaling by GPCR—CDK5—Alzheimer's disease	2.97e-05	0.00129	CbGpPWpGaD
Reboxetine—SLC6A4—Circadian rythm related genes—MAPK8—Alzheimer's disease	2.93e-05	0.00128	CbGpPWpGaD
Reboxetine—HTR2C—Signaling by GPCR—HTR6—Alzheimer's disease	2.86e-05	0.00125	CbGpPWpGaD
Reboxetine—SLC6A4—SIDS Susceptibility Pathways—TNF—Alzheimer's disease	2.84e-05	0.00124	CbGpPWpGaD
Reboxetine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—CREB1—Alzheimer's disease	2.83e-05	0.00123	CbGpPWpGaD
Reboxetine—SLC6A2—NRF2 pathway—TGFB1—Alzheimer's disease	2.76e-05	0.0012	CbGpPWpGaD
Reboxetine—ABCB1—Transmembrane transport of small molecules—APOD—Alzheimer's disease	2.75e-05	0.0012	CbGpPWpGaD
Reboxetine—HTR2C—Class A/1 (Rhodopsin-like receptors)—CCR5—Alzheimer's disease	2.68e-05	0.00117	CbGpPWpGaD
Reboxetine—HTR2C—Class A/1 (Rhodopsin-like receptors)—HTR2A—Alzheimer's disease	2.63e-05	0.00114	CbGpPWpGaD
Reboxetine—HTR2C—GPCR downstream signaling—GAL—Alzheimer's disease	2.61e-05	0.00114	CbGpPWpGaD
Reboxetine—ABCB1—Allograft Rejection—IL1B—Alzheimer's disease	2.56e-05	0.00111	CbGpPWpGaD
Reboxetine—ABCB1—Allograft Rejection—CASP3—Alzheimer's disease	2.55e-05	0.00111	CbGpPWpGaD
Reboxetine—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—Alzheimer's disease	2.52e-05	0.0011	CbGpPWpGaD
Reboxetine—ABCB1—HIF-1-alpha transcription factor network—VEGFA—Alzheimer's disease	2.5e-05	0.00109	CbGpPWpGaD
Reboxetine—HTR2C—Signaling by GPCR—GAL—Alzheimer's disease	2.37e-05	0.00103	CbGpPWpGaD
Reboxetine—CYP3A4—Biological oxidations—PTGS1—Alzheimer's disease	2.37e-05	0.00103	CbGpPWpGaD
Reboxetine—ABCB1—Integrated Pancreatic Cancer Pathway—BAX—Alzheimer's disease	2.34e-05	0.00102	CbGpPWpGaD
Reboxetine—SLC6A2—Transmembrane transport of small molecules—HMOX1—Alzheimer's disease	2.33e-05	0.00101	CbGpPWpGaD
Reboxetine—CYP3A4—Biological oxidations—CYP2D6—Alzheimer's disease	2.33e-05	0.00101	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—TTR—Alzheimer's disease	2.31e-05	0.00101	CbGpPWpGaD
Reboxetine—HTR2C—Class A/1 (Rhodopsin-like receptors)—F2—Alzheimer's disease	2.3e-05	0.001	CbGpPWpGaD
Reboxetine—SLC6A4—SIDS Susceptibility Pathways—IL6—Alzheimer's disease	2.29e-05	0.001	CbGpPWpGaD
Reboxetine—CYP3A4—Metapathway biotransformation—CYP2D6—Alzheimer's disease	2.29e-05	0.000999	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—DHCR24—Alzheimer's disease	2.18e-05	0.00095	CbGpPWpGaD
Reboxetine—ABCB1—Allograft Rejection—VEGFA—Alzheimer's disease	2.16e-05	0.000943	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—DHCR24—Alzheimer's disease	2.06e-05	0.000896	CbGpPWpGaD
Reboxetine—HTR2C—GPCR downstream signaling—NPY—Alzheimer's disease	2.05e-05	0.000895	CbGpPWpGaD
Reboxetine—HTR2C—Class A/1 (Rhodopsin-like receptors)—CCL2—Alzheimer's disease	2.05e-05	0.000894	CbGpPWpGaD
Reboxetine—SLC6A4—Circadian rythm related genes—TP53—Alzheimer's disease	2.05e-05	0.000892	CbGpPWpGaD
Reboxetine—HTR2C—GPCR ligand binding—CCR5—Alzheimer's disease	2.04e-05	0.00089	CbGpPWpGaD
Reboxetine—HTR2C—GPCR downstream signaling—IAPP—Alzheimer's disease	2.04e-05	0.000889	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—PYY—Alzheimer's disease	2.02e-05	0.000881	CbGpPWpGaD
Reboxetine—HTR2C—GPCR ligand binding—HTR2A—Alzheimer's disease	2e-05	0.000871	CbGpPWpGaD
Reboxetine—ABCB1—Allograft Rejection—TGFB1—Alzheimer's disease	1.99e-05	0.000866	CbGpPWpGaD
Reboxetine—HTR2C—GPCR downstream signaling—CRH—Alzheimer's disease	1.98e-05	0.000863	CbGpPWpGaD
Reboxetine—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—Alzheimer's disease	1.89e-05	0.000823	CbGpPWpGaD
Reboxetine—HTR2C—GPCR downstream signaling—NPS—Alzheimer's disease	1.88e-05	0.000818	CbGpPWpGaD
Reboxetine—SLC6A4—Circadian rythm related genes—IL6—Alzheimer's disease	1.87e-05	0.000816	CbGpPWpGaD
Reboxetine—HTR2C—Signaling by GPCR—NPY—Alzheimer's disease	1.86e-05	0.000812	CbGpPWpGaD
Reboxetine—ABCB1—Allograft Rejection—TNF—Alzheimer's disease	1.86e-05	0.000808	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—CA4—Alzheimer's disease	1.85e-05	0.000808	CbGpPWpGaD
Reboxetine—HTR2C—Signaling by GPCR—IAPP—Alzheimer's disease	1.85e-05	0.000807	CbGpPWpGaD
Reboxetine—HTR2C—Signaling by GPCR—CRH—Alzheimer's disease	1.8e-05	0.000784	CbGpPWpGaD
Reboxetine—HTR2C—GPCR downstream signaling—GAB2—Alzheimer's disease	1.79e-05	0.000781	CbGpPWpGaD
Reboxetine—HTR2C—GPCR downstream signaling—SST—Alzheimer's disease	1.79e-05	0.000781	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—CDK5—Alzheimer's disease	1.75e-05	0.000764	CbGpPWpGaD
Reboxetine—HTR2C—GPCR ligand binding—F2—Alzheimer's disease	1.75e-05	0.000764	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—CA4—Alzheimer's disease	1.75e-05	0.000762	CbGpPWpGaD
Reboxetine—HTR2C—GPCR downstream signaling—APP—Alzheimer's disease	1.75e-05	0.000761	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—GAPDHS—Alzheimer's disease	1.74e-05	0.00076	CbGpPWpGaD
Reboxetine—ABCB1—Transmembrane transport of small molecules—CP—Alzheimer's disease	1.72e-05	0.000751	CbGpPWpGaD
Reboxetine—HTR2C—Signaling by GPCR—NPS—Alzheimer's disease	1.71e-05	0.000743	CbGpPWpGaD
Reboxetine—ABCB1—Integrated Pancreatic Cancer Pathway—CREB1—Alzheimer's disease	1.7e-05	0.000741	CbGpPWpGaD
Reboxetine—HTR2C—Signaling by GPCR—PPP3CA—Alzheimer's disease	1.7e-05	0.000739	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—HTR6—Alzheimer's disease	1.69e-05	0.000736	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—ATP5A1—Alzheimer's disease	1.65e-05	0.00072	CbGpPWpGaD
Reboxetine—HTR2C—GPCR downstream signaling—PLCB1—Alzheimer's disease	1.65e-05	0.000718	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—GAPDHS—Alzheimer's disease	1.64e-05	0.000716	CbGpPWpGaD
Reboxetine—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—Alzheimer's disease	1.64e-05	0.000713	CbGpPWpGaD
Reboxetine—HTR2C—Signaling by GPCR—GAB2—Alzheimer's disease	1.63e-05	0.000709	CbGpPWpGaD
Reboxetine—HTR2C—Signaling by GPCR—SST—Alzheimer's disease	1.63e-05	0.000709	CbGpPWpGaD
Reboxetine—ABCB1—HIF-1-alpha transcription factor network—AKT1—Alzheimer's disease	1.6e-05	0.000695	CbGpPWpGaD
Reboxetine—HTR2C—Signaling by GPCR—APP—Alzheimer's disease	1.59e-05	0.000691	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—PLD3—Alzheimer's disease	1.58e-05	0.000687	CbGpPWpGaD
Reboxetine—HTR2C—GPCR ligand binding—CCL2—Alzheimer's disease	1.56e-05	0.000681	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—ATP5A1—Alzheimer's disease	1.56e-05	0.000679	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—PSENEN—Alzheimer's disease	1.53e-05	0.000668	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—HSD17B10—Alzheimer's disease	1.51e-05	0.000659	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—APH1A—Alzheimer's disease	1.51e-05	0.000659	CbGpPWpGaD
Reboxetine—HTR2C—Signaling by GPCR—PLCB1—Alzheimer's disease	1.5e-05	0.000652	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—PLD3—Alzheimer's disease	1.49e-05	0.000648	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—NCSTN—Alzheimer's disease	1.47e-05	0.000641	CbGpPWpGaD
Reboxetine—ABCB1—Transmembrane transport of small molecules—TF—Alzheimer's disease	1.47e-05	0.000639	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—CYP46A1—Alzheimer's disease	1.46e-05	0.000634	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—LRP1—Alzheimer's disease	1.44e-05	0.000625	CbGpPWpGaD
Reboxetine—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—Alzheimer's disease	1.43e-05	0.000622	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—HSD17B10—Alzheimer's disease	1.42e-05	0.000621	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—ND1—Alzheimer's disease	1.41e-05	0.000612	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—GAL—Alzheimer's disease	1.4e-05	0.000611	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—GFAP—Alzheimer's disease	1.4e-05	0.000611	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—CYP46A1—Alzheimer's disease	1.37e-05	0.000598	CbGpPWpGaD
Reboxetine—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—Alzheimer's disease	1.36e-05	0.000591	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—DHCR24—Alzheimer's disease	1.34e-05	0.000586	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—ND1—Alzheimer's disease	1.32e-05	0.000577	CbGpPWpGaD
Reboxetine—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—Alzheimer's disease	1.26e-05	0.000549	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—A2M—Alzheimer's disease	1.24e-05	0.000538	CbGpPWpGaD
Reboxetine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—Alzheimer's disease	1.23e-05	0.000536	CbGpPWpGaD
Reboxetine—HTR2C—GPCR downstream signaling—PRKCG—Alzheimer's disease	1.22e-05	0.000531	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—PSEN2—Alzheimer's disease	1.2e-05	0.000521	CbGpPWpGaD
Reboxetine—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK8—Alzheimer's disease	1.16e-05	0.000504	CbGpPWpGaD
Reboxetine—HTR2C—GPCR downstream signaling—CCR5—Alzheimer's disease	1.15e-05	0.000503	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—CA4—Alzheimer's disease	1.14e-05	0.000498	CbGpPWpGaD
Reboxetine—HTR2C—GPCR downstream signaling—HTR2A—Alzheimer's disease	1.13e-05	0.000492	CbGpPWpGaD
Reboxetine—HTR2C—Signaling by GPCR—PRKCG—Alzheimer's disease	1.11e-05	0.000482	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—NPY—Alzheimer's disease	1.1e-05	0.00048	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—IAPP—Alzheimer's disease	1.09e-05	0.000477	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—GAPDHS—Alzheimer's disease	1.07e-05	0.000468	CbGpPWpGaD
Reboxetine—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—Alzheimer's disease	1.07e-05	0.000465	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—CRH—Alzheimer's disease	1.06e-05	0.000463	CbGpPWpGaD
Reboxetine—HTR2C—Signaling by GPCR—CCR5—Alzheimer's disease	1.05e-05	0.000457	CbGpPWpGaD
Reboxetine—HTR2C—Signaling by GPCR—HTR2A—Alzheimer's disease	1.03e-05	0.000447	CbGpPWpGaD
Reboxetine—ABCB1—Transmembrane transport of small molecules—HMOX1—Alzheimer's disease	1.03e-05	0.000447	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—ATP5A1—Alzheimer's disease	1.02e-05	0.000444	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—NPS—Alzheimer's disease	1.01e-05	0.000439	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—PPP3CA—Alzheimer's disease	1e-05	0.000437	CbGpPWpGaD
Reboxetine—HTR2C—GPCR downstream signaling—F2—Alzheimer's disease	9.9e-06	0.000432	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—PTK2B—Alzheimer's disease	9.88e-06	0.00043	CbGpPWpGaD
Reboxetine—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—Alzheimer's disease	9.81e-06	0.000427	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—PLD3—Alzheimer's disease	9.72e-06	0.000423	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—NTRK2—Alzheimer's disease	9.61e-06	0.000419	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—SST—Alzheimer's disease	9.61e-06	0.000419	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—GAB2—Alzheimer's disease	9.61e-06	0.000419	CbGpPWpGaD
Reboxetine—HTR2C—Signaling by GPCR—CALM1—Alzheimer's disease	9.57e-06	0.000417	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—GSK3A—Alzheimer's disease	9.53e-06	0.000415	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—APP—Alzheimer's disease	9.37e-06	0.000408	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—HSD17B10—Alzheimer's disease	9.32e-06	0.000406	CbGpPWpGaD
Reboxetine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—Alzheimer's disease	9.16e-06	0.000399	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—TPI1—Alzheimer's disease	9.06e-06	0.000395	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—CHAT—Alzheimer's disease	9.06e-06	0.000395	CbGpPWpGaD
Reboxetine—HTR2C—Signaling by GPCR—F2—Alzheimer's disease	8.99e-06	0.000392	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—CYP46A1—Alzheimer's disease	8.97e-06	0.000391	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—PLCB1—Alzheimer's disease	8.84e-06	0.000385	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—MAOB—Alzheimer's disease	8.69e-06	0.000378	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—ND1—Alzheimer's disease	8.66e-06	0.000377	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—CHAT—Alzheimer's disease	8.54e-06	0.000372	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—TPI1—Alzheimer's disease	8.54e-06	0.000372	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—GAPDH—Alzheimer's disease	8.36e-06	0.000364	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—NGFR—Alzheimer's disease	8.25e-06	0.000359	CbGpPWpGaD
Reboxetine—HTR2C—Signaling by GPCR—CREB1—Alzheimer's disease	8.19e-06	0.000357	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—MAOB—Alzheimer's disease	8.18e-06	0.000357	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—A2M—Alzheimer's disease	8.07e-06	0.000352	CbGpPWpGaD
Reboxetine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—Alzheimer's disease	8.07e-06	0.000352	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—ADAM10—Alzheimer's disease	8.05e-06	0.000351	CbGpPWpGaD
Reboxetine—HTR2C—Signaling by GPCR—CCL2—Alzheimer's disease	8.02e-06	0.000349	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—GAPDH—Alzheimer's disease	7.88e-06	0.000343	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—S100B—Alzheimer's disease	7.62e-06	0.000332	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—A2M—Alzheimer's disease	7.61e-06	0.000331	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—IGF2—Alzheimer's disease	7.25e-06	0.000316	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—ACHE—Alzheimer's disease	7.02e-06	0.000306	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—IGF1R—Alzheimer's disease	7.01e-06	0.000305	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—INPP5D—Alzheimer's disease	6.94e-06	0.000302	CbGpPWpGaD
Reboxetine—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—Alzheimer's disease	6.82e-06	0.000297	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—LPL—Alzheimer's disease	6.72e-06	0.000293	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—MEF2C—Alzheimer's disease	6.66e-06	0.00029	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—ACHE—Alzheimer's disease	6.62e-06	0.000288	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—PTGS1—Alzheimer's disease	6.58e-06	0.000287	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—ENO1—Alzheimer's disease	6.58e-06	0.000287	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—INPP5D—Alzheimer's disease	6.54e-06	0.000285	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—PRKCG—Alzheimer's disease	6.54e-06	0.000285	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—CYP2D6—Alzheimer's disease	6.45e-06	0.000281	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—NGF—Alzheimer's disease	6.37e-06	0.000277	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—ENO1—Alzheimer's disease	6.2e-06	0.00027	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—PTGS1—Alzheimer's disease	6.2e-06	0.00027	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—CCR5—Alzheimer's disease	6.19e-06	0.00027	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—BCHE—Alzheimer's disease	6.12e-06	0.000267	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—HTR2A—Alzheimer's disease	6.06e-06	0.000264	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—PLCB1—Alzheimer's disease	5.77e-06	0.000252	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—BCHE—Alzheimer's disease	5.77e-06	0.000251	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—CALM1—Alzheimer's disease	5.65e-06	0.000246	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—APOE—Alzheimer's disease	5.63e-06	0.000245	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—LEP—Alzheimer's disease	5.63e-06	0.000245	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—ABCA1—Alzheimer's disease	5.6e-06	0.000244	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—CAV1—Alzheimer's disease	5.58e-06	0.000243	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—CHAT—Alzheimer's disease	5.58e-06	0.000243	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—TPI1—Alzheimer's disease	5.58e-06	0.000243	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—PLCB1—Alzheimer's disease	5.44e-06	0.000237	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—ESR1—Alzheimer's disease	5.38e-06	0.000234	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—MAOB—Alzheimer's disease	5.35e-06	0.000233	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—F2—Alzheimer's disease	5.31e-06	0.000231	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—ABCA1—Alzheimer's disease	5.27e-06	0.00023	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—NOTCH1—Alzheimer's disease	5.2e-06	0.000227	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—GAPDH—Alzheimer's disease	5.15e-06	0.000224	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—A2M—Alzheimer's disease	4.97e-06	0.000217	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—GSK3B—Alzheimer's disease	4.88e-06	0.000213	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—CREB1—Alzheimer's disease	4.84e-06	0.000211	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—PPARGC1A—Alzheimer's disease	4.82e-06	0.00021	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—INS—Alzheimer's disease	4.81e-06	0.00021	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—HMOX1—Alzheimer's disease	4.8e-06	0.000209	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—CCL2—Alzheimer's disease	4.74e-06	0.000206	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—IGF1—Alzheimer's disease	4.66e-06	0.000203	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—PPARGC1A—Alzheimer's disease	4.55e-06	0.000198	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—HMOX1—Alzheimer's disease	4.52e-06	0.000197	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—LPL—Alzheimer's disease	4.39e-06	0.000191	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—ACHE—Alzheimer's disease	4.33e-06	0.000189	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—INPP5D—Alzheimer's disease	4.28e-06	0.000186	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—NOS3—Alzheimer's disease	4.22e-06	0.000184	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—LPL—Alzheimer's disease	4.14e-06	0.00018	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—ENO1—Alzheimer's disease	4.06e-06	0.000177	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—PTGS1—Alzheimer's disease	4.06e-06	0.000177	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—CYP2D6—Alzheimer's disease	3.98e-06	0.000173	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—MTHFR—Alzheimer's disease	3.95e-06	0.000172	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—BCHE—Alzheimer's disease	3.77e-06	0.000164	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—MTHFR—Alzheimer's disease	3.73e-06	0.000162	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—CALM1—Alzheimer's disease	3.69e-06	0.000161	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—APOE—Alzheimer's disease	3.68e-06	0.00016	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—CAV1—Alzheimer's disease	3.65e-06	0.000159	CbGpPWpGaD
Reboxetine—HTR2C—GPCR downstream signaling—AKT1—Alzheimer's disease	3.62e-06	0.000158	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—CASP3—Alzheimer's disease	3.58e-06	0.000156	CbGpPWpGaD
Reboxetine—HTR2C—Signaling by GPCR—IL6—Alzheimer's disease	3.56e-06	0.000155	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—PLCB1—Alzheimer's disease	3.56e-06	0.000155	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—CALM1—Alzheimer's disease	3.48e-06	0.000152	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—APOE—Alzheimer's disease	3.47e-06	0.000151	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—ABCA1—Alzheimer's disease	3.45e-06	0.00015	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—CAV1—Alzheimer's disease	3.44e-06	0.00015	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—MAPK8—Alzheimer's disease	3.29e-06	0.000143	CbGpPWpGaD
Reboxetine—HTR2C—Signaling by GPCR—AKT1—Alzheimer's disease	3.28e-06	0.000143	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—PPARG—Alzheimer's disease	3.21e-06	0.00014	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—INS—Alzheimer's disease	3.14e-06	0.000137	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—VEGFA—Alzheimer's disease	3.04e-06	0.000132	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—PPARG—Alzheimer's disease	3.02e-06	0.000132	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—PPARGC1A—Alzheimer's disease	2.97e-06	0.000129	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—INS—Alzheimer's disease	2.96e-06	0.000129	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—HMOX1—Alzheimer's disease	2.96e-06	0.000129	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—TGFB1—Alzheimer's disease	2.79e-06	0.000122	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—NOS3—Alzheimer's disease	2.76e-06	0.00012	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—LPL—Alzheimer's disease	2.71e-06	0.000118	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—NOS3—Alzheimer's disease	2.6e-06	0.000113	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—PTGS2—Alzheimer's disease	2.52e-06	0.00011	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—MTHFR—Alzheimer's disease	2.44e-06	0.000106	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—PTGS2—Alzheimer's disease	2.38e-06	0.000104	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—TP53—Alzheimer's disease	2.3e-06	0.0001	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—CALM1—Alzheimer's disease	2.28e-06	9.92e-05	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—APOE—Alzheimer's disease	2.27e-06	9.88e-05	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—CAV1—Alzheimer's disease	2.25e-06	9.79e-05	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—IL6—Alzheimer's disease	2.1e-06	9.16e-05	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—PPARG—Alzheimer's disease	1.98e-06	8.61e-05	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—AKT1—Alzheimer's disease	1.94e-06	8.45e-05	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—INS—Alzheimer's disease	1.94e-06	8.44e-05	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—NOS3—Alzheimer's disease	1.7e-06	7.4e-05	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—PTGS2—Alzheimer's disease	1.55e-06	6.77e-05	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—AKT1—Alzheimer's disease	1.27e-06	5.52e-05	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—AKT1—Alzheimer's disease	1.19e-06	5.2e-05	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—AKT1—Alzheimer's disease	7.81e-07	3.4e-05	CbGpPWpGaD
